Journal
JOURNAL OF INTERNAL MEDICINE
Volume 250, Issue 6, Pages 462-475Publisher
WILEY
DOI: 10.1046/j.1365-2796.2001.00911.x
Keywords
cancer; immunotherapy; melanoma; antigens; interleukin-2
Categories
Funding
- Intramural NIH HHS [Z01 SC003811-33] Funding Source: Medline
Ask authors/readers for more resources
Several recent developments have hallmarked progress in tumour immunology and immunotherapy. The use of interleukin-2 (IL-2) in cancer patients demonstrated that an immunological manipulation was capable of mediating the regression of established growing cancers in humans. The identification of the genes encoding cancer antigens and the development of means for effectively immunizing patients against these antigens has opened important new avenues of exploration for the development of effective active and cell-transfer immunotherapies for patients with cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available